These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1111351)

  • 1. The relative resistance of dengue-immune monkeys to yellow fever virus.
    Theiler M; Anderson CR
    Am J Trop Med Hyg; 1975 Jan; 24(1):115-7. PubMed ID: 1111351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue-2 vaccine: viremia and immune responses in rhesus monkeys.
    Scott RM; Nisalak A; Eckels KH; Tingpalapong M; Harrison VR; Gould DJ; Chapple FE; Russell PK
    Infect Immun; 1980 Jan; 27(1):181-6. PubMed ID: 6766903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.
    Schlesinger JJ; Brandriss MW; Cropp CB; Monath TP
    J Virol; 1986 Dec; 60(3):1153-5. PubMed ID: 3783816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological sensitization following inapparent infection with dengue virus type 3 in rhesus monkeys.
    Lubiniecki AS; Tarr GC
    Experientia; 1977 Mar; 33(3):330-1. PubMed ID: 404181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody.
    Halstead SB
    J Infect Dis; 1979 Oct; 140(4):527-33. PubMed ID: 117061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status.
    Scott RM; Eckels KH; Bancroft WH; Summers PL; McCown JM; Anderson JH; Russell PK
    J Infect Dis; 1983 Dec; 148(6):1055-60. PubMed ID: 6655288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
    Guirakhoo F; Arroyo J; Pugachev KV; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Soike K; Ratterree M; Monath TP
    J Virol; 2001 Aug; 75(16):7290-304. PubMed ID: 11462001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirect immunofluorescence, serum neutralization, and viremia responses of rhesus monkeys (Macaca mulatta) to Machupo virus.
    Gonder E; Eddy G
    J Med Virol; 1986 Jun; 19(2):187-92. PubMed ID: 3014062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the sequential immunization against group B arboviruses in squirrel monkeys, cynomolgus monkeys, rhesus monkeys, and chimpanzees.
    Price WH; Casals J; O'Leary W
    Am J Trop Med Hyg; 1974 Jan; 23(1):118-30. PubMed ID: 4204022
    [No Abstract]   [Full Text] [Related]  

  • 12. Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates.
    Harrison VR; Eckels KH; Sagartz JW; Russell PK
    Infect Immun; 1977 Oct; 18(1):151-6. PubMed ID: 409682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood value changes in flavivirus-inoculated Macaca fascicularis monkeys.
    Angsubhakorn S; Yoksan S; Henchal EA; Nisalak A; Hoke CH; Pradermwong A; Sahaphong S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):1-7. PubMed ID: 2874612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arbovirus studies in Luanda, Angola. 1. Virological and serological studies during a yellow fever epidemic.
    Pinto MR; Filipe AR
    Bull World Health Organ; 1973; 49(1):31-5. PubMed ID: 4545154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of viraemia and limited antibody response of dengue virus immune rhesus monkeys after vaccination with DEN-2/S-1 vaccine.
    Kraiselburd E; Kessler MJ; Torres-Blasini G
    Trans R Soc Trop Med Hyg; 1984; 78(4):445-8. PubMed ID: 6548325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
    GROOT H
    Bull World Health Organ; 1962; 27(6):709-15. PubMed ID: 13950709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies with group B arthropod-borne viruses. V. Evaluation of cross-immunity against type 1 dengue fever in human subjects convalescent from subclinical natural Japanese encephalitis virus infection and vaccinated with 17D strain yellow fever vaccine.
    Wisseman CL; Kitaoka M; Tamiya T
    Am J Trop Med Hyg; 1966 Jul; 15(4):588-600. PubMed ID: 4287392
    [No Abstract]   [Full Text] [Related]  

  • 19. Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.
    Guirakhoo F; Kitchener S; Morrison D; Forrat R; McCarthy K; Nichols R; Yoksan S; Duan X; Ermak TH; Kanesa-Thasan N; Bedford P; Lang J; Quentin-Millet MJ; Monath TP
    Hum Vaccin; 2006; 2(2):60-7. PubMed ID: 17012873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.